Coronary heart disease in Diabetics: Difference between revisions

Jump to navigation Jump to search
← Older editNewer edit →
VisualWikitext
/* 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.f...
/* 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.f...
Line 35: Line 35:
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Screening for diabetes is recommended in all individuals with CVD, using fasting glucose and/or HbA1C<ref name="pmid33298413">{{cite journal| author=American Diabetes Association| title=2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. | journal=Diabetes Care | year= 2021 | volume= 44 | issue= Suppl 1 | pages= S15-S33 | pmid=33298413 | doi=10.2337/dc21-S002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33298413  }} </ref><ref name="pmid20978099">{{cite journal| author=Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K | display-authors=etal| title=Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. | journal=Diabetes Care | year= 2011 | volume= 34 | issue= 1 | pages= 145-50 | pmid=20978099 | doi=10.2337/dc10-1206 | pmc=3005450 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20978099  }} </ref><ref name="pmid27216887">{{cite journal| author=Sattar N, Preiss D| title=Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. | journal=Lancet Diabetes Endocrinol | year= 2016 | volume= 4 | issue= 7 | pages= 555-6 | pmid=27216887 | doi=10.1016/S2213-8587(16)30097-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27216887  }} </ref><ref name="pmid35022686">{{cite journal| author=Mak KH, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I | display-authors=etal| title=Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. | journal=Eur J Prev Cardiol | year= 2022 | volume= 28 | issue= 16 | pages= 1795-1806 | pmid=35022686 | doi=10.1093/eurjpc/zwab011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35022686  }} </ref>
| bgcolor="LightGreen"|<nowiki>"</nowiki>'''1.'''Screening for diabetes is recommended in all individuals with CVD, using fasting glucose and/or HbA1C<ref name="pmid33298413">{{cite journal| author=American Diabetes Association| title=2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021. | journal=Diabetes Care | year= 2021 | volume= 44 | issue= Suppl 1 | pages= S15-S33 | pmid=33298413 | doi=10.2337/dc21-S002 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=33298413  }} </ref><ref name="pmid20978099">{{cite journal| author=Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K | display-authors=etal| title=Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes. | journal=Diabetes Care | year= 2011 | volume= 34 | issue= 1 | pages= 145-50 | pmid=20978099 | doi=10.2337/dc10-1206 | pmc=3005450 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20978099  }} </ref><ref name="pmid27216887">{{cite journal| author=Sattar N, Preiss D| title=Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure. | journal=Lancet Diabetes Endocrinol | year= 2016 | volume= 4 | issue= 7 | pages= 555-6 | pmid=27216887 | doi=10.1016/S2213-8587(16)30097-3 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27216887  }} </ref><ref name="pmid35022686">{{cite journal| author=Mak KH, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I | display-authors=etal| title=Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities. | journal=Eur J Prev Cardiol | year= 2022 | volume= 28 | issue= 16 | pages= 1795-1806 | pmid=35022686 | doi=10.1093/eurjpc/zwab011 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=35022686  }} </ref>
'''2.'''It is recommended that the diagnosis of diabetes is based on HbA1C and/or fasting plasma glucose, or on an OGTT if still in doubt<ref name="pmid12502614">{{cite journal| author=Expert Committee on the Diagnosis and Classification of Diabetes Mellitus| title=Report of the expert committee on the diagnosis and classification of diabetes mellitus. | journal=Diabetes Care | year= 2003 | volume= 26 Suppl 1 | issue=  | pages= S5-20 | pmid=12502614 | doi=10.2337/diacare.26.2007.s5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12502614  }} </ref><ref name="pmid20067953">{{cite journal| author=Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS | display-authors=etal| title=Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. | journal=Diabetes Care | year= 2010 | volume= 33 | issue= 3 | pages= 562-8 | pmid=20067953 | doi=10.2337/dc09-1524 | pmc=2827508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20067953  }} </ref><ref name="pmid30425094">{{cite journal| author=Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P| title=Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. | journal=Diabetes Care | year= 2018 | volume= 41 | issue= 12 | pages= 2648-2668 | pmid=30425094 | doi=10.2337/dci18-0052 | pmc=7732108 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30425094  }} </ref>
'''2.'''It is recommended that the diagnosis of diabetes is based on HbA1C and/or fasting plasma glucose, or on an OGTT if still in doubt<ref name="pmid12502614">{{cite journal| author=Expert Committee on the Diagnosis and Classification of Diabetes Mellitus| title=Report of the expert committee on the diagnosis and classification of diabetes mellitus. | journal=Diabetes Care | year= 2003 | volume= 26 Suppl 1 | issue=  | pages= S5-20 | pmid=12502614 | doi=10.2337/diacare.26.2007.s5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12502614  }} </ref><ref name="pmid20067953">{{cite journal| author=Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS | display-authors=etal| title=Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. | journal=Diabetes Care | year= 2010 | volume= 33 | issue= 3 | pages= 562-8 | pmid=20067953 | doi=10.2337/dc09-1524 | pmc=2827508 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20067953  }} </ref><ref name="pmid30425094">{{cite journal| author=Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P| title=Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association. | journal=Diabetes Care | year= 2018 | volume= 41 | issue= 12 | pages= 2648-2668 | pmid=30425094 | doi=10.2337/dci18-0052 | pmc=7732108 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30425094  }} </ref>
===Recommendations for assessing cardiovascular risk in patients with type 2 diabetes<ref name="pmid37622663">{{cite journal| author=Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ | display-authors=etal| title=2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes. | journal=Eur Heart J | year= 2023 | volume= 44 | issue= 39 | pages= 4043-4140 | pmid=37622663 | doi=10.1093/eurheartj/ehad192 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=37622663  }} </ref>===


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{WH}}{{WS}}
{{WH}}{{WS}}

Revision as of 06:51, 21 December 2023

2016 ADA Guideline Recommendations

Types of Diabetes Mellitus

Main Diabetes Page

Diabetes type I

Diabetes type II

Gestational Diabetes Mellitus

2016 ADA Standard of Medical Care Guideline Recommendations

Strategies for Improving Care

Classification and Diagnosis of Diabetes

Foundations of Care and Comprehensive Medical Evaluation

Diabetes Self-Management, Education, and Support
Nutritional Therapy

Prevention or Delay of Type II Diabetes

Glycemic Targets

Obesity Management for Treatment of Type II Diabetes

Approaches to Glycemic Treatment

Cardiovascular Disease and Risk Management

Hypertension and Blood Pressure Control
Lipid Management
Antiplatelet Agents
Coronary Heart Disease

Microvascular Complications and Foot Care

Diabetic Kidney Disease
Diabetic Retinopathy
Diabetic Neuropathy
Diabetic Footcare

Older Adults with Diabetes

Children and Adolescents with Diabetes

Management of Cardiovascular Risk Factors in Children and Adolescents with Diabetes
Microvascular Complications in Children and Adolescents with Diabetes

Management of Diabetes in Pregnancy

Diabetes Care in the Hospital Setting

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shivani Chaparala M.B.B.S [2]; Seyedmahdi Pahlavani, M.D. [3]; Tarek Nafee, M.D. [4]

2016 ADA Standards of Medical Care in Diabetes Guidelines[1]

Screening

"1.In asymptomatic patients, routine screening for coronary artery disease is not recommended as it does not improve outcomes as long as atherosclerotic cardiovascular disease risk factors are treated (Level of Evidence: A)"
"2. Consider investigations for coronary artery disease in the presence of any of the following: atypical cardiac symptoms (e.g., unexplained dyspnea, chest discomfort); signs or symptoms of associated vascular disease including carotid bruits, transient ischemic attack, stroke, claudication, or peripheral arterial disease; or electrocardiogram abnormalities (e.g., Q waves) (Level of Evidence: E)"

Treatment

"1.In patients with known atherosclerotic cardiovascular disease, use aspirin and statin therapy (if not contraindicated) "(Level of Evidence: A)" and consider ACE inhibitor therapy. (Level of Evidence: C) to reduce the risk of cardiovascular events."
"2.In patients with prior myocardial infarction, b-blockers should be continued for at least 2 years after the event (Level of Evidence: B)"
"3.In patients with symptomatic heart failure, thiazolidinedione treatment should not be used (Level of Evidence: A)"
"4.In patients with type 2 diabetes with stable congestive heart failure, metformin may be used if renal function is normal but should be avoided in unstable or hospitalized patients with congestive heart failure (Level of Evidence: B)"

2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes[2]

Recommendations for diagnosing diabetes[2]

Class I
"1.Screening for diabetes is recommended in all individuals with CVD, using fasting glucose and/or HbA1C[3][4][5][6]

2.It is recommended that the diagnosis of diabetes is based on HbA1C and/or fasting plasma glucose, or on an OGTT if still in doubt[7][8][9]

Recommendations for assessing cardiovascular risk in patients with type 2 diabetes[2]

References

  1. ↑ "care.diabetesjournals.org" (PDF).
  2. ↑ 2.0 2.1 2.2 Marx N, Federici M, Schütt K, Müller-Wieland D, Ajjan RA, Antunes MJ; et al. (2023). "2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes". Eur Heart J. 44 (39): 4043–4140. doi:10.1093/eurheartj/ehad192. PMID 37622663 Check |pmid= value (help).
  3. ↑ American Diabetes Association (2021). "2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021". Diabetes Care. 44 (Suppl 1): S15–S33. doi:10.2337/dc21-S002. PMID 33298413 Check |pmid= value (help).
  4. ↑ Colagiuri S, Lee CM, Wong TY, Balkau B, Shaw JE, Borch-Johnsen K; et al. (2011). "Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes". Diabetes Care. 34 (1): 145–50. doi:10.2337/dc10-1206. PMC 3005450. PMID 20978099.
  5. ↑ Sattar N, Preiss D (2016). "Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure". Lancet Diabetes Endocrinol. 4 (7): 555–6. doi:10.1016/S2213-8587(16)30097-3. PMID 27216887.
  6. ↑ Mak KH, Vidal-Petiot E, Young R, Sorbets E, Greenlaw N, Ford I; et al. (2022). "Prevalence of diabetes and impact on cardiovascular events and mortality in patients with chronic coronary syndromes, across multiple geographical regions and ethnicities". Eur J Prev Cardiol. 28 (16): 1795–1806. doi:10.1093/eurjpc/zwab011. PMID 35022686 Check |pmid= value (help).
  7. ↑ Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003). "Report of the expert committee on the diagnosis and classification of diabetes mellitus". Diabetes Care. 26 Suppl 1: S5–20. doi:10.2337/diacare.26.2007.s5. PMID 12502614.
  8. ↑ Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS; et al. (2010). "Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006". Diabetes Care. 33 (3): 562–8. doi:10.2337/dc09-1524. PMC 2827508. PMID 20067953.
  9. ↑ Arslanian S, Bacha F, Grey M, Marcus MD, White NH, Zeitler P (2018). "Evaluation and Management of Youth-Onset Type 2 Diabetes: A Position Statement by the American Diabetes Association". Diabetes Care. 41 (12): 2648–2668. doi:10.2337/dci18-0052. PMC 7732108 Check |pmc= value (help). PMID 30425094.

Template:WHTemplate:WS

Retrieved from "https://www.wikidoc.org/index.php?title=Coronary_heart_disease_in_Diabetics&oldid=1736681"